Speaker(s): 

Craig Riccelli, MD, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Dominick Agosi, LCSW, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Understand treatment resistant depression.
  • Describe various treatment options for major depressive disorder.
  • Identify important considerations for pharmacologic treatment.
  • Recognize potential barriers to enhance treatment adherence.

 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Nidhi Karingula, MD, Craig Riccelli, MD, Dominick Agosi, LCSW, DeAnn Hansum, PA-C, Lauryn Eister, NP, Corey Haupt, PharmD, RPh, Priya Marpuri, MD and McCarey Bast, PhD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.

Session date: 
04/02/2024 - 1:00pm to 2:00pm EDT
Location: 
Virtual Meeting
United States
  • 1.00 AAPA Category I CME
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit

Please login or register to take this course.